Rosacea

This study tests whether microfocused ultrasound can safely improve facial pigmentary diseases (like melasma) and rosacea. Two hundred adults will be randomly assigned to receive either real ultrasound or a sham (fake) treatment once a month for six months. Researchers will track…

This study looks at whether Cligabalin (HSK16149) can help people with a type of rosacea that causes severe burning and tingling on the face. It includes 60 adults whose redness and discomfort did not improve with standard treatments. The main goal is to see if the drug reduces f…

This Phase 2 trial tests a gel called lotilaner for people with moderate to severe ocular rosacea, a condition causing red, irritated eyes. About 155 adults will receive either the gel or a placebo to see if it is safe and helps symptoms. The study is currently enrolling by invit…

This study tested a cream called ATR-04 to see if it could safely reduce the facial rash caused by certain cancer drugs (EGFR inhibitors). About 60 adults with cancer who were about to start these drugs were planned to join. The study was withdrawn before any participants enrolle…

This study looks at the bacteria living on the skin and in the gut of people with moderate to severe rosacea compared to healthy volunteers. Researchers want to find unique bacterial patterns in rosacea patients and see how these change after four weeks of antibiotic treatment. T…

This study looks at how different doses of the antibiotic doxycycline affect antibiotic resistance in people with ocular rosacea, an inflammatory eye condition. Researchers will compare a low anti-inflammatory dose (40 mg daily) with a standard antibiotic dose (200 mg daily) and …

This study looks at whether artificial intelligence (AI) can match a dermatologist's diagnosis when a general practitioner sends in photos and questions about a patient's skin condition. Researchers will compare the AI's diagnosis to the dermatologist's for about 1000 adults. The…